SEC Form 4 · accession 0001365618-16-000008

Anacor Pharmaceuticals, Inc. · ANAC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Anders D Hove

Director

Period of report

Apr 14, 2016

Accepted (ET)

Apr 15, 2016 · 9:14 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001411158

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2,F3	Apr 14, 2016	C	257,647	$31.05	A	353,881	I	By Funds and LLC's
Common Stock^F4	holding	—	—		—	33,886	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
2.00% Convertible Senior Notes due 2021^F5	$31.05	Apr 14, 2016	C	—	D	—	Oct 15, 2021	Common Stock	257,647	—	I

Explanation of responses

F1The conversions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Venrock Healthcare Capital Partners, L.P. ("VHCP"), VHCP Co-Investment Holdings, LLC ("VHCP Co-Invest"), Venrock Healthcare Capital Partners II, L.P. ("VHCP II"), VHCP Co-Investment Holdings II, LLC ("VHCP Co-Invest II"), Venrock Associates IV, L.P. ("VA4"), Venrock Partners, L.P. ("VP") and Venrock Entreprenerus Fund IV, L.P. ("VEF4") on March 16, 2016.
F2The shares are held as follows: 44,464 shares held by VA4, 9,068 shares held by VP, 1,092 shares held by VEF4, 100,521 shares held by VHCP, 18,383 shares held by VHCP Co-Invest, 151,658 shares held by VHCP II, and 28,695 shares held by VHCP Co-Invest II.
F3Venrock Management IV, LLC ("VM4"), Venrock Partners Management, LLC ("VPM") and VEF Management IV, LLC ("VEFM4") are the sole general partners of VA4, VP and VEF4, respectively, and may be deemed to beneficially own these shares. VHCP Management, LLC ("VHCP Management") is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. VHCP Management II, LLC ("VHCP Management II") is the general partner of VHCP II and the manager of VHCP Co-Invest II and may be deemed to beneficially own these shares. Anders Hove is a member of VM4, VPM and VEFM4 and a managing member of VHCP Management and VHCP Management II. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA4, VP, VEF4, VHCP, VHCP Co-Invest, VHCP II, VHCP Co-Invest II, VM4, VPM, VEFM4, VHCP Management and VHCP Management II except to the extent of his indirect pecuniary interest therein.
F4The reporting person is a member of VR Management, LLC (the "Management Company"). Under an agreement between the reporting person and the Management Company, the reporting person is deemed to hold an aggregate of 794 of the reported securities for the sole benefit of the Management Company (the "Management Company Shares"). The Management Company may be deemed the indirect beneficial owner of the Management Company Shares, and the reporting person may be deemed the indirect beneficial owner of the Management Company Shares through his interest in the Management Company. The reporting person disclaims beneficial ownership of the Management Company Shares except to the extent of his indirect pecuniary interest therein.
F5The 2.00% Convertible Senior Notes due 2021 were convertible into common stock at a conversion price equal to $31.05 (32.2061 shares of common stock for each $1,000 worth of principal) on the date of conversion.